Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01139541
Other study ID # WalkStation1
Secondary ID
Status Completed
Phase N/A
First received June 3, 2010
Last updated August 17, 2015
Start date June 2010
Est. completion date January 2011

Study information

Verified date August 2015
Source Harvard University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of the study is to learn more about effective ways to motivate people to increase their non-exercise energy expenditure exercise. This is an important research question because obesity and weight-related issues are increasingly becoming a problem in America. This project will address this research question by testing the effect of group dynamics in motivating employees who are predominantly sedentary to use Walkstations at work. The Walkstations are treadmills that move at a very slow rate (maximum 2miles / hour) and are attached to a work station (i.e. with computer and telephone); they therefore are designed to increase energy spent not through heavy exercise, but through small changes in posture and movement associated with routines in daily life (called nonexercise activity thermogenesis or NEAT). The proposed study is designed to build upon previous research (Levine et al., 2005) suggesting the role of NEAT-enhanced behaviors in weight loss.

In this study, the investigators are interested in the impact of group dynamics on the propensity to use the Walkstations. Participants in the active arms will be asked to use the Walkstations for at least 3 hours per week. They will do so by signing up for a time slot. During their session, they will be asked to log into the scheduling system to indicate that they are using the Walkstation. Walkstation usage will be assessed by log-in data: employees will log-in to the phone and computer when they use the Walkstation. This log-in data is work-station specific; therefore the investigators will be able to tell when a given subject used the Walkstation.

Subjects will be randomly assigned to one of three conditions:

1. Individual. In the individual condition, participants will not be part of a team. They will receive weekly email feedback on their Walkstation performance (e.g. number of time slots they signed up for, and number of times they showed up for the time slot.) Participants will also receive a wellness tip in each email. (see appendix for a sample email)

2. Pairs. In the pair condition, participants will be randomly assigned to a partner. They will receive the same feedback as those in the individual condition, for both themselves AND their partner.

3. Group. In the group condition, participants will be randomly assigned to a group of 5 people. They will receive the same feedback as those in the individual condition, for both themselves AND each member of their group.


Recruitment information / eligibility

Status Completed
Enrollment 224
Est. completion date January 2011
Est. primary completion date January 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Must pass the ParQ

- Must be employee of BCBS Massachusetts

Exclusion Criteria:

- Failing the ParQ

- Not being an employee of BCBS Massachusetts

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Social walking intervention
In this intervention, we are interested in the impact of group dynamics on the propensity to use the Walkstations. The intervention consists of 4 levels: control, individual, pair, and group.

Locations

Country Name City State
United States Blue Cross Blue Shield Massachusetts Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Harvard University Blue Cross Blue Shield

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary WalkStation usage Frequency with which the participant uses the WalkStation 3 months No
Secondary Creativity Creativity measured on versus off the WalkStation. 3 months No
Secondary Focus Focus, as measured when person is on versus off the WalkStation. 3 months No
Secondary Health Behaviors Survey Survey of health-related behaviors to be completed by participant. pre-baseline No
Secondary WalkStation Usage Frequency with which the participant uses the WalkStation 6 months No
Secondary Health Behaviors Survey Survey of health-related behaviors to be completed by participant. baseline No
Secondary Health Behaviors Survey Survey of health-related behaviors to be completed by participant. 6 months No
Secondary Creativity Creativity measured on versus off the WalkStation. baseline No
Secondary Focus Focus, as measured when person is on versus off the WalkStation. baseline No
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2